CompoAtlas

COLLAGENE ACIDE HYALURONIQUE COENZYME Q10

Food supplement declared in France, decision dated 19 November 2025

COLLAGENE ACIDE HYALURONIQUE COENZYME Q10 (Exceldiet Pharma) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: acide hyaluronique 30 mg per day, ubiquinone 15 mg per day, Acacia senegal 200 mg per day, Collagène marin. None of the rules we check flags an issue with its declared composition.

Brand
Exceldiet Pharma
Food business operator placing the product on the market
EXCELDIET PHARMA
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
1 comprimé
Directions for use
1 comprimé par jour avec un grand verre d'eau.
Intended populations
General population
Not recommended (according to the manufacturer)
Adolescents (under 18), Children (under 12)
Objectives stated by the manufacturer (these are not authorised claims)
Skin, Joints, Hair and nails

Declaration 344217, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Acacia senegal (L.) Willd.GommePoudre (de plantes séchées ou broyées)200 mg

Substances

NamePer day
acide hyaluronique30 mg
ubiquinone15 mg

Other active ingredients

NamePer day
Collagène marinnot declared

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne se substitue pas à une alimentation variée et équilibrée et à un mode de vie sain. Ne pas dépasser la dose journalière recommandée. Réservé à l’adulte. Tenir hors de portée des jeunes enfants. À conserver au sec, à l’abri de la chaleur et de la lumière. Convient aux végétariens et aux végans.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • ubiquinone
    Read the warning, when it applies and the studies cited

    Coenzyme Q10 (UBIQUINONE-10)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).

    Sources cited by Health Canada (2)
    • Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
    • Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial

    Applies to products providing more than 100 mg of Coenzyme Q10 per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).

    Sources cited by Health Canada (3)
    • Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
    • Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
    • Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report

    Condition of application: Migraine prophylaxis/prevention.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Exceldiet Pharma

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “COLLAGENE ACIDE HYALURONIQUE COENZYME Q10 (Exceldiet Pharma): composition and regulation”, https://compoatlas.com/en/supplements/products/344217-collagene-acide-hyaluronique-coenzyme-q10, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line